These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 34283811)
1. TNFRSF13B genotypes control immune-mediated pathology by regulating the functions of innate B cells. de Mattos Barbosa MG; Lefferts AR; Huynh D; Liu H; Zhang Y; Fu B; Barnes J; Samaniego M; Bram RJ; Geha RS; Shikanov A; Prak ETL; Farkash EA; Platt JL; Cascalho M JCI Insight; 2021 Sep; 6(17):. PubMed ID: 34283811 [TBL] [Abstract][Full Text] [Related]
2. TNF receptor superfamily member 13b (TNFRSF13B) hemizygosity reveals transmembrane activator and CAML interactor haploinsufficiency at later stages of B-cell development. Romberg N; Virdee M; Chamberlain N; Oe T; Schickel JN; Perkins T; Cantaert T; Rachid R; Rosengren S; Palazzo R; Geha R; Cunningham-Rundles C; Meffre E J Allergy Clin Immunol; 2015 Nov; 136(5):1315-25. PubMed ID: 26100089 [TBL] [Abstract][Full Text] [Related]
3. TNFRSF13B in B cell responses to organ transplantation. Cascalho M; Platt JL Hum Immunol; 2023 Jan; 84(1):27-33. PubMed ID: 36333165 [TBL] [Abstract][Full Text] [Related]
4. Cascalho M; Platt JL Front Immunol; 2021; 12():634544. PubMed ID: 33679786 [TBL] [Abstract][Full Text] [Related]
6. Passive transfer of alloantibodies restores acute cardiac rejection in IgKO mice. Wasowska BA; Qian Z; Cangello DL; Behrens E; Van Tran K; Layton J; Sanfilippo F; Baldwin WM Transplantation; 2001 Mar; 71(6):727-36. PubMed ID: 11330533 [TBL] [Abstract][Full Text] [Related]
7. An evolutionary approach to the medical implications of the tumor necrosis factor receptor superfamily member 13B (TNFRSF13B) gene. Sazzini M; Zuntini R; Farjadian S; Quinti I; Ricci G; Romeo G; Ferrari S; Calafell F; Luiselli D Genes Immun; 2009 Sep; 10(6):566-78. PubMed ID: 19494827 [TBL] [Abstract][Full Text] [Related]
8. The C104R mutant impairs the function of transmembrane activator and calcium modulator and cyclophilin ligand interactor (TACI) through haploinsufficiency. Lee JJ; Jabara HH; Garibyan L; Rauter I; Sannikova T; Dillon SR; Bram R; Geha RS J Allergy Clin Immunol; 2010 Dec; 126(6):1234-41.e2. PubMed ID: 20889194 [TBL] [Abstract][Full Text] [Related]
9. Shinya Y; Hiraide T; Momoi M; Goto S; Suzuki H; Katsumata Y; Kurebayashi Y; Endo J; Sano M; Fukuda K; Kosaki K; Kataoka M J Am Heart Assoc; 2021 Feb; 10(5):e019245. PubMed ID: 33586470 [TBL] [Abstract][Full Text] [Related]
11. Donor Polymorphisms in Genes Related to B-Cell Biology Associated With Antibody-Mediated Rejection After Heart Transplantation. Marrón-Liñares GM; Núñez L; Crespo-Leiro MG; Álvarez-López E; Barge-Caballero E; Barge-Caballero G; Couto-Mallón D; Pradas-Irun C; Muñiz J; Tan C; Rodríguez ER; Vázquez-Rodríguez JM; Hermida-Prieto M Circ J; 2018 Apr; 82(5):1351-1359. PubMed ID: 29618707 [TBL] [Abstract][Full Text] [Related]
12. The C76R transmembrane activator and calcium modulator cyclophilin ligand interactor mutation disrupts antibody production and B-cell homeostasis in heterozygous and homozygous mice. Bacchelli C; Buckland KF; Buckridge S; Salzer U; Schneider P; Thrasher AJ; Gaspar HB J Allergy Clin Immunol; 2011 May; 127(5):1253-9.e13. PubMed ID: 21458042 [TBL] [Abstract][Full Text] [Related]
13. A gain-of-function mutation in TNFRSF13B is a candidate for predisposition to familial or sporadic immune thrombocytopenia. Peng HL; Zhang Y; Sun NN; Yin YF; Wang YW; Cheng Z; Yan WZ; Liu SF; Xu YX; Xiao X; Zhang GS J Thromb Haemost; 2017 Nov; 15(11):2259-2269. PubMed ID: 28834165 [TBL] [Abstract][Full Text] [Related]
14. In the absence of natural killer cell activation donor-specific antibody mediates chronic, but not acute, kidney allograft rejection. Yagisawa T; Tanaka T; Miyairi S; Tanabe K; Dvorina N; Yokoyama WM; Valujskikh A; Baldwin WM; Fairchild RL Kidney Int; 2019 Feb; 95(2):350-362. PubMed ID: 30503624 [TBL] [Abstract][Full Text] [Related]
15. Deficiency in TNFRSF13B (TACI) expands T-follicular helper and germinal center B cells via increased ICOS-ligand expression but impairs plasma cell survival. Ou X; Xu S; Lam KP Proc Natl Acad Sci U S A; 2012 Sep; 109(38):15401-6. PubMed ID: 22949644 [TBL] [Abstract][Full Text] [Related]
16. The murine equivalent of the A181E TACI mutation associated with common variable immunodeficiency severely impairs B-cell function. Lee JJ; Rauter I; Garibyan L; Ozcan E; Sannikova T; Dillon SR; Cruz AC; Siegel RM; Bram R; Jabara H; Geha RS Blood; 2009 Sep; 114(11):2254-62. PubMed ID: 19605846 [TBL] [Abstract][Full Text] [Related]
17. Transmembrane activator and CAML interactor (TACI) haploinsufficiency results in B-cell dysfunction in patients with Smith-Magenis syndrome. Chinen J; Martinez-Gallo M; Gu W; Cols M; Cerutti A; Radigan L; Zhang L; Potocki L; Withers M; Lupski JR; Cunningham-Rundles C J Allergy Clin Immunol; 2011 Jun; 127(6):1579-86. PubMed ID: 21514638 [TBL] [Abstract][Full Text] [Related]
18. Methylation of TNFRSF13B and TNFRSF13C in duodenal mucosa in canine inflammatory bowel disease and its association with decreased mucosal IgA expression. Maeda S; Ohno K; Fujiwara-Igarashi A; Tomiyasu H; Fujino Y; Tsujimoto H Vet Immunol Immunopathol; 2014 Jul; 160(1-2):97-106. PubMed ID: 24814046 [TBL] [Abstract][Full Text] [Related]
19. The role of B cells and alloantibody in the host response to human organ allografts. Vongwiwatana A; Tasanarong A; Hidalgo LG; Halloran PF Immunol Rev; 2003 Dec; 196():197-218. PubMed ID: 14617206 [TBL] [Abstract][Full Text] [Related]
20. Long-term control of alloreactive B cell responses by the suppression of T cell help. Li Y; Ma L; Yin D; Shen J; Chong AS J Immunol; 2008 May; 180(9):6077-84. PubMed ID: 18424729 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]